Manila Times Business
Oncotelic Therapeutics Inc. (OTCQB: OTLC) Eyeing Nanotech-Driven Delivery Systems, Pharmacokinetic Optimization to Advance Existing Oncology Therapies
NEW YORK, June 04, 2026 (GLOBE NEWSWIRE) -- via BioMedWire -- Oncotelic Therapeutics Inc. (OTCQB: OTLC) today announces its placement in an editorial published by BioMedWire (BMW), one of 75+ brands within the Dynamic Brand Portfolio@IBN (InvestorBrandNetwork), a specialized communications platform with a focus on financial news and content distribution for private and public companies and the investment community. To view the full publication, "Platform Biotech Models Draw Investor Eyes as Drug
This is an excerpt. Read the full article at the original source:
Source: manilatimes.net
Read Full Article on manilatimes.net →More from Manila Times Business
HM Exploration Drills Massive Sulphide at Lewis Pilley’s Project
2h ago
Fate Therapeutics Showcases Data from FT819 and FT839 Programs at the European Congress of Rheumatology Annual Meeting
2h ago
GoldHaven Advances Copeçal Toward Q3 Drilling; Identifies Priority Eastern Targets
2h ago
Satellogic Appoints Lieutenant General (Ret.) Michael E. Williamson to its Board of Directors
2h ago